The Wellcome Trust, a private non-profit openly aligned with the Clinton Foundation and a regular participant in the Clinton Global Initiative, funded a study to determine if a donated cadaver uterus can be surgically transplanted into the body of a biological male.
The study, published by the National Institute for Health (NIH), also sought to determine if a baby could be ethically, legally, and medically brought to full term with the procedure.
It concluded that, while the procedure carries significant risk to the transplant patient, “The reproductive aspirations of M2F transgender women deserve equal consideration to those assigned female at birth and, subject to feasibility being shown in the suggested areas of research, it may be legally and ethically impermissible not to consider performing UTx in this population.”
They expounded upon the legal implications by noting that current civil rights law may prevent denying patients this type of procedure based on gender identity.
“Ethically, the consideration of performing UTx in transgender women is primarily motivated by the considerations of justice and equality.”
The Wellcome Trust isn’t the first organization to pursue this kind of dangerous research, however. The Cleveland Institute, also affiliated with the NIH, performed the procedure in 2019 that resulted in the “first baby in North America using a uterus transplanted from a deceased donor.” This procedure was performed on a biological female.
ICYMI: Cleveland Clinic delivers the first baby in North America using a uterus transplanted from a deceased donor.
Learn more: https://t.co/Jr6KTLVk2R pic.twitter.com/wfUY7pWf7j
— Cleveland Clinic (@ClevelandClinic) July 9, 2019
At least 80 womb transplants have been performed in over 10 countries (excluding Canada) worldwide since the first baby was born following a uterine transplant in Sweden in 2014. Since that time, more than 35 babies have been delivered via womb transplants.
In a different study, published by the NIH in January, author Alireza Jahromi fantasizes about the issue’s ability to upend the nuclear family structure, declaring, “In modern society, acceptance of gender diversity and fluidity is increasing; however, parenthood is still largely considered to be a binary construct. A hypothetical case of a transgender woman who undergoes uterus transplant and carries a pregnancy conceived with her own sperm is presented.”
She continues, “This situation raises unique ethical and legal issues regarding the parental designation of the transgender woman…Should ‘motherhood’ and ‘fatherhood’ be based on parental genetic contribution to the child?”
Clinical trials for womb transplants are expected to come to a close in early 2025, according to ClinicalTrials.gov, which keeps a record of these trials for the NIH.
When the clinical trials end for genetic womb transplants, which already carry significant ethical considerations, the scientific community will immediately begin trials for transplants into men.
During these trials, patients are expected to suffer from the procedures and embryos will fail repetitively as they tinker with the male human body to make it capable of carrying a child to term. Additionally, these horrific procedures will impact families suffering from grief after having lost a loved one, only to learn that their mother, wife, or daughters’ womb was given to a man because she unwittingly opted to become an organ donor on her driver’s license.
This selfless act of kindness, in which the donor expected that her organs would be used to save a life, would instead result in her donated womb performing de-facto abortions and unnatural scientific experiments without her having expressly given consent.
The Wellcome Trust could not be reached for comment on the nature of their studies or the extent of their relationship with the Clinton Global Initiative.
